As the naysayers were claiming too much magnesium etc etc, we were busy building ponds and an industrial-scale pilot plant to demonstrate potential and viability.
Next thing you know, we were producing battery-grade carbonate and shipping to potential end-user customers for qualification.
Based on actual product and actual processing, using equipment and processes that enabled assessment of scalability (as opposed to simply making product in a lab, proving technical viability and then making bulk assumptions and estimates wrt commercial-scale production), we have estimated up-scaled production factors - equipment/energy/water/costs etc and have high-confidence of a commercially-viable project.
Simple.
But, for some reason, you want readers here to believe your vague “conclusions” and guesswork over a team with decades of experience, led by a Li brine processing expert, that is ticking boxes continuously towards the end goal.
Why?
What evidence do you have?
What reasoning?
I call BS FUD.
The 2000tpa plant will likely have a higher production cost than the PEA proposed for a 10ktpa plant, but as others have mentioned, product prices are well above twice what that estimate was, so:
The 2ktpa plant is likely to be profitable in its own right (JZ has also noted this btw),
But, more importantly, the 2ktpa plant is merely a very short-term stepping stone towards that 10ktpa (and possibly larger) eventual operation.
The 2ktpa plant allows momentum to continue and further de-risks the next stage.
Simple.
The naysayers are being proven wrong, time after time, again and again.
Simple.
That 20-tonne BG shipment must have brought a tear to your eye!
The company has runs on the board and demonstrable progress to support its project’s viability.
What have you got?
- Forums
- ASX - By Stock
- AGY
- Ann: $30M Placement to Fund 2,000tpa Production
AGY
argosy minerals limited
Add to My Watchlist
20.0%
!
1.8¢

Ann: $30M Placement to Fund 2,000tpa Production, page-151
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.8¢ |
Change
0.003(20.0%) |
Mkt cap ! $26.20M |
Open | High | Low | Value | Volume |
1.6¢ | 2.3¢ | 1.6¢ | $899.2K | 44.43M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
11 | 1745031 | 1.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.0¢ | 1134176 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
11 | 1745031 | 0.018 |
9 | 2644117 | 0.017 |
10 | 1438810 | 0.016 |
16 | 2638023 | 0.015 |
34 | 6549845 | 0.014 |
Price($) | Vol. | No. |
---|---|---|
0.020 | 1134176 | 6 |
0.021 | 1680234 | 10 |
0.022 | 2164025 | 9 |
0.023 | 4231366 | 9 |
0.024 | 2006009 | 11 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
AGY (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online